{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Safety was assessed at all visits and adverse events were recorded.","groups":[{"description":"At doses from 300mg/day up to 1200mg/day","id":"OG000","title":"Mifepristone"}],"paramType":"NUMBER","populationDescription":"Due to the small number of patients enrolled (N=4), no formal assessments were planned. All patients who received study drug were included in the safety review.","reportingStatus":"POSTED","timeFrame":"6 months","title":"Number of Participants With Adverse Events","type":"PRIMARY","unitOfMeasure":"participants"}